The multiple sclerosis functional composite measure (MSFC): An integrated approach to MS clinical outcome assessment

Multiple Sclerosis

Volumn 5, Issue 4, 1999, Pages 244-250

  Fischer, J S ^a   Rudick, R A ^a   Cutter, G R ^b   Reingold, S C ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c National MS Society   (United States)

Author keywords

Clinical outcome assessment; Clinical trials; MS functional composite (MSFC); Multiple sclerosis

Indexed keywords

CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; HUMAN; LIMB MOVEMENT; MOBILIZATION; MULTIPLE SCLEROSIS; SCORING SYSTEM;

EID: 0032837796     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500409     Document Type: Conference Paper

References (25)

1. Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis; An expanded disability status scale (EDSS). Neurology 33: 1444-1452.
2. Whitaker JN, McFarland HF, Rudge P, Reingold SC. (1995) Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis 1: 37-47.
3. Sipe JC et al. (1984) A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 34: 1368-1372.
4. Cook SD et al. (1986) Effect of total lymphoid irradiation in chronic progressive multiple sclerosis. Lancet 1: 1405-1409.
5. Ravnborg M, Grønberg-Jensen M, Jonsson A. (1997) The MS impairment scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis. Multiple Sclerosis 3: 31-42.
6. Potvin AR, Tourtellotte WW. (1985) Quantitative examination of neurologic function. Vol II. Methodology for test and patient assessments and design of a computer-automated system. Boca Rator, FL: CRC Press.
7. Rudick RA et al. (1996) Clinical outcomes assessment in multiple sclerosis. Ann Neurol 40: 469-479.
8. Syndulko K et al. (1996) Comparative evaluations of neuroperformance and clinical outcome assessments in multiple sclerosis. I. Primary dimensions, construct validation and sensitivity to disease progression. Multiple Sclerosis 2: 142-156.
9. Petkau AJ. (1996) Statistical and design considerations for multiple sclerosis clinical trials. In Goodkin DE, Rudick RA (eds.), Multiple sclerosis: advances in clinical trial design, treatment, and future perspectives. London: Springer pp 63-103.
10. Goldsmith CH, Smythe HA, Helawa A. (1993) Interpretation and power of a pooled index. J Rheumatol 20: 575-578.
11. Rudick RA et al. (1997) Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 42: 379-382.
12. Ellison GW et al. (1989) A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. Neurology 39: 1018-1026.
13. The Multiple Sclerosis Study Group. (1990) Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. Ann Neurol 27: 591-605.
14. Goodkin DE et al. (1995) Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 37: 30-40.
15. Jacobs LD et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39: 285-294.
16. Cutter GR et al. (1999) Development of a Multiple Sclerosis Functional Composite as a clinical trial outcome measure. Brain 122: 87-88.
17. Fischer JS et al. (1999). Administration and scoring manual for the MS Functional Composite measure (MSFC). New York: Demos.
18. Schwid SR et al. (1997) The measurement of ambulatory impairment in multiple sclerosis. Neurology 49: 1419-1424.
19. Goodkin D, Hertsgaard D, Seminary J. (1988) Upper extremity function in multiple sclerosis: improving assessment sensitivity with Box-and-Block and 9-Hole Peg Tests. Arch Phys Med Rehabil 69: 850-854.
20. Gronwall D. (1977) Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills 44: 363-373.
21. Rao S et al. (1989) Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39: 161-166.
22. Fischer JS et al. Intra- and inter-rater reliability of the Multiple Sclerosis Functional Composite. Neurology 52: A50.
23. Bever CT, Grattan L, Panitch HS, Johnson KP. (1995) The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study. Multiple Sclerosis 1: 165-169.
24. Syndulko K et al. (1993) Neuroperformance evaluation of multiple sclerosis disease progression in a clinical trial: implications for neurological outcomes. J Neuro Rehab 7: 153-176.
25. Brooks BR et al. (1994) The natural history of amyotrophic lateral sclerosis. In AC Williams (ed.) Motor neuron disease. New York: Chapman & Hall Medical pp 131-169.